The COMBINED Study to Integrate Health Behaviour Change for People With a Rotator Cuff Disorder
COMBINED
COmbining Brief Interventions for Modifiable Health Behaviours withIN a Physiotherapy Consultation for pEople With a Rotator Cuff Disorder: Development and Testing in a Single-arm Feasibility Study
1 other identifier
interventional
25
1 country
4
Brief Summary
COMBINED is a pragmatic single-arm feasibility study. The goal of this study is to evaluate the implementation of a physiotherapy-led intervention, The COMBINED approach, to facilitate ongoing refinements, including the strategies for implementation, in readiness for a definitive trial in people with a rotator cuff disorder. The main questions it aims to answer are: 1) What are the key domains of behaviour change influencing the implementation of The COMBINED approach among physiotherapists? 2) Can The COMBINED approach be delivered as intended? 3) Are there any refinements required to the intervention components? 4) What is the patient experience of receiving The COMBINED approach in an NHS setting?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedStudy Start
First participant enrolled
July 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 25, 2023
CompletedAugust 9, 2024
August 1, 2024
4 months
March 21, 2023
August 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
To assess a change in the Determinants of Behavior Questionnaire (DIBQ)
Physiotherapy self-report survey
At baseline (0 months) and study completion (expected at 6 months)
Fidelity of intervention delivery (self-report checklist by the physiotherapists) will be reported descriptively
What intervention components were delivered by the physiotherapists as intended
6 months
Fidelity of intervention delivery (observed through audio-recordings by the research team) will be reported descriptively
What intervention components were delivered by the physiotherapists as intended
6 months
Secondary Outcomes (1)
Number of patients recruited that have one or more of the identified lifestyle factor will be reported descriptively
6 months
Study Arms (1)
Intervention arm
EXPERIMENTALThis is a single arm interventional study. 1. A patient-level intervention, which includes: * An assessment of existing lifestyle factors (smoking status, physical activity levels, and weight) that may be relevant to shoulder pain; * A brief intervention to support health behaviour change with respect to the target behaviours of smoking cessation, increasing physical activity levels and consuming a healthy diet * Supporting tools for behaviour change, including an activity workbook for goal-setting and a diary for self-monitoring (attached). The intervention is to be delivered by physiotherapists, integrated within a routine consultation for people with a RC disorder. 2. A clinician-level implementation toolkit to support the delivery of the clinical intervention, which includes a training package and additional resources e.g. scripts to aid conversations with patients.
Interventions
1. Patient-level intervention: * Assessment of existing lifestyle factors (smoking status, physical activity levels, and weight) that may be relevant to shoulder pain; * Brief intervention to support health behaviour change: smoking cessation, increasing physical activity levels and consuming a healthy diet * Supporting tools for behaviour change, including an activity workbook for goal-setting and a diary for self-monitoring. 2. Clinician-level implementation toolkit: * Training package including a face-to-face workshop, training manual, recorded role play simulations and an online follow-up training session * Additional supporting resources; a step-by-step guide to The COMBINED approach, scripts, patient signposting information to support services and a lay summary infographic to explain the links between the health behaviours and RC disorders to patients * Audit and feedback via observations of consultations to address any 'drift' from the intervention delivery as intended
Eligibility Criteria
You may qualify if:
- A qualified (HCPC registered) physiotherapist involved in the management of patients with a RC disorder at one of the trial sites;
- Willing to consent to the study procedures, including attending a training workshop, audio-recording of the consultations and audit/feedback on intervention delivery.
- Adult (aged 18 or over);
- Diagnosed with a RC disorder as per the diagnostic criteria in the British Elbow and Shoulder Society guidelines (Kulkarni et al., 2015), which includes pain mid-range on abduction movement, pain on resisted tests and no loss of external rotation, along with screening of the neck and ruling out other conditions (e.g., instability/frozen shoulder). This will be confirmed by the site Principal Investigators (PI), specialist HCPC registered physiotherapists;
- Able to attend at least one face-to-face physiotherapy consultation. Eligibility will be confirmed via physical examination at this session as per the criteria above;
- Able to give full informed consent;
- Willing to consent to the study procedures, including audio-recording of the consultations.
You may not qualify if:
- Significant trauma;
- Neurological or inflammatory causes of their shoulder pain;
- Any clinical indications of serious pathology.
- We will not exclude anyone based upon protected characteristics for example, age and ethnicity. Anyone referred into the physiotherapy department with a RC disorder will be eligible to take part in the study. Measures in place may include support for the consent process, consultation or patient interviews where required, for example, if verbal translation is needed via a hospital interpreter, personal interpreter or telephone translation service.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Julie Burylead
- Manchester Metropolitan Universitycollaborator
Study Sites (4)
University Hospitals of Leicester
Leicester, Leicestershire, LE1 5WW, United Kingdom
Doncaster and Bassetlaw NHS Foundation Trust
Doncaster, South Yorkshire, DN2 5LT, United Kingdom
Calderdale and Huddersfield NHS Foundation Trsut
Halifax, West Yorkshire, HX3 0PW, United Kingdom
Airedale Foundation Trust
Keighley, West Yorkshire, BD20 6TD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Julie Bury
Manchester Metropolitan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- N/A, study does not involve pharmaceutical products or medical devices. There is no randomisation involved in this study.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- HEE/NIHR Clinical Doctoral Research Fellow
Study Record Dates
First Submitted
March 21, 2023
First Posted
April 25, 2023
Study Start
July 3, 2023
Primary Completion
October 25, 2023
Study Completion
October 25, 2023
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be available to other researchers